Wt Wealth Management Abb Vie Inc. Transaction History

Wt Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $149,868 - $186,501	1,131 Added 18.05%	7,397 $996,000
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $906,126 - $1.04 Million	6,266 New	6,266 $998,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $210,640 - $261,345	-1,596 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $171,458 - $216,944	1,596 New	1,596 $216,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wt Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Wt Wealth Management with notifications on news.